News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) Reports Fourth Quarter And Full Year 2013 Financial Results


2/27/2014 6:36:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAVAL, Quebec, Feb. 27, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces fourth quarter financial results for 2013.

Fourth Quarter 2013

-- 2013 Fourth Quarter Total Revenue $2.1 billion; an increase of 109% over the prior year

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES